4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-086171
Chief Financial Officer bought 10,000 shares at $2.00 ($20,000)
From the SEC's structured data for this filing
Trades in this filing
Payne Fletcher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-12-17 | Purchase : show line 1 in the form | +10,000 | $2.00 | $20,000 | 25,032 | I |
| Open-market purchases · 10,000 sh · avg $2.00 · $20,000 | ||||||
Loading xslF345X03/doc4.xml…